Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2015-11, Vol.26, p.vii109
Hauptverfasser: Motomura, Sayuri, Suda, Atsuhiro, Inoue, Misato, Takashi, Yoshikawa, Atsushi, Yamamoto, Hiroko, Hidai, Hisashi, Tsutsumi, Junichi, Nagashima
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page vii109
container_title Annals of oncology
container_volume 26
creator Motomura, Sayuri
Suda, Atsuhiro
Inoue, Misato
Takashi, Yoshikawa
Atsushi, Yamamoto
Hiroko, Hidai
Hisashi, Tsutsumi
Junichi, Nagashima
description
doi_str_mv 10.1093/annonc/mdv472.16
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdv472_16</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdv472_16</sourcerecordid><originalsourceid>FETCH-LOGICAL-c836-e74a40d95a41540c84698542c15f1b7337fa266873215d87276bcc0633ac2d1c3</originalsourceid><addsrcrecordid>eNotkDtPwzAYRT2ARCnsjP4Dbv2KHY9QlYdUiaULU_TFDwhK7Mpxgfx7SsN0dXWlo6uD0B2jK0aNWEOMKdr14L6k5iumLtCCGi6IroS8Qtfj-EkpVYabBSrbEDoLdsIpYEPfSNfmrhyHNECLS3f88QUiLtlDGXwsOKSMs-_hMHqHIbpTCRlsSXnCffom7xmcxw_E-r4_7wPE0nt87v00HD5O5Bt0GaAf_e1_LtH-cbvfPJPd69PL5n5HbC0U8VqCpM5UIFklqa2lMnUluWVVYK0WQgfgStVacFa5WnOtWmupEgIsd8yKJaIz1uY0jqejzSF3A-SpYbT5E9XMoppZVMOU-AWL82F-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Motomura, Sayuri ; Suda, Atsuhiro ; Inoue, Misato ; Takashi, Yoshikawa ; Atsushi, Yamamoto ; Hiroko, Hidai ; Hisashi, Tsutsumi ; Junichi, Nagashima</creator><creatorcontrib>Motomura, Sayuri ; Suda, Atsuhiro ; Inoue, Misato ; Takashi, Yoshikawa ; Atsushi, Yamamoto ; Hiroko, Hidai ; Hisashi, Tsutsumi ; Junichi, Nagashima</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdv472.16</identifier><language>eng</language><ispartof>Annals of oncology, 2015-11, Vol.26, p.vii109</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Motomura, Sayuri</creatorcontrib><creatorcontrib>Suda, Atsuhiro</creatorcontrib><creatorcontrib>Inoue, Misato</creatorcontrib><creatorcontrib>Takashi, Yoshikawa</creatorcontrib><creatorcontrib>Atsushi, Yamamoto</creatorcontrib><creatorcontrib>Hiroko, Hidai</creatorcontrib><creatorcontrib>Hisashi, Tsutsumi</creatorcontrib><creatorcontrib>Junichi, Nagashima</creatorcontrib><title>Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNotkDtPwzAYRT2ARCnsjP4Dbv2KHY9QlYdUiaULU_TFDwhK7Mpxgfx7SsN0dXWlo6uD0B2jK0aNWEOMKdr14L6k5iumLtCCGi6IroS8Qtfj-EkpVYabBSrbEDoLdsIpYEPfSNfmrhyHNECLS3f88QUiLtlDGXwsOKSMs-_hMHqHIbpTCRlsSXnCffom7xmcxw_E-r4_7wPE0nt87v00HD5O5Bt0GaAf_e1_LtH-cbvfPJPd69PL5n5HbC0U8VqCpM5UIFklqa2lMnUluWVVYK0WQgfgStVacFa5WnOtWmupEgIsd8yKJaIz1uY0jqejzSF3A-SpYbT5E9XMoppZVMOU-AWL82F-</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Motomura, Sayuri</creator><creator>Suda, Atsuhiro</creator><creator>Inoue, Misato</creator><creator>Takashi, Yoshikawa</creator><creator>Atsushi, Yamamoto</creator><creator>Hiroko, Hidai</creator><creator>Hisashi, Tsutsumi</creator><creator>Junichi, Nagashima</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201511</creationdate><title>Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma</title><author>Motomura, Sayuri ; Suda, Atsuhiro ; Inoue, Misato ; Takashi, Yoshikawa ; Atsushi, Yamamoto ; Hiroko, Hidai ; Hisashi, Tsutsumi ; Junichi, Nagashima</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c836-e74a40d95a41540c84698542c15f1b7337fa266873215d87276bcc0633ac2d1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Motomura, Sayuri</creatorcontrib><creatorcontrib>Suda, Atsuhiro</creatorcontrib><creatorcontrib>Inoue, Misato</creatorcontrib><creatorcontrib>Takashi, Yoshikawa</creatorcontrib><creatorcontrib>Atsushi, Yamamoto</creatorcontrib><creatorcontrib>Hiroko, Hidai</creatorcontrib><creatorcontrib>Hisashi, Tsutsumi</creatorcontrib><creatorcontrib>Junichi, Nagashima</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Motomura, Sayuri</au><au>Suda, Atsuhiro</au><au>Inoue, Misato</au><au>Takashi, Yoshikawa</au><au>Atsushi, Yamamoto</au><au>Hiroko, Hidai</au><au>Hisashi, Tsutsumi</au><au>Junichi, Nagashima</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma</atitle><jtitle>Annals of oncology</jtitle><date>2015-11</date><risdate>2015</risdate><volume>26</volume><spage>vii109</spage><pages>vii109-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdv472.16</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2015-11, Vol.26, p.vii109
issn 0923-7534
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdv472_16
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Efficacy of 90Y-ibritumomab tiuxetan treatment for relapsed and refractory low-grade B-cell and mantle cell lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T22%3A46%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%2090Y-ibritumomab%20tiuxetan%20treatment%20for%20relapsed%20and%20refractory%20low-grade%20B-cell%20and%20mantle%20cell%20lymphoma&rft.jtitle=Annals%20of%20oncology&rft.au=Motomura,%20Sayuri&rft.date=2015-11&rft.volume=26&rft.spage=vii109&rft.pages=vii109-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdv472.16&rft_dat=%3Ccrossref%3E10_1093_annonc_mdv472_16%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true